Where is the live CopyMark page for USPTO serial 79230420?

The live record is at https://getcopymark.com/trademark/79230420. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns RECIPHARM PATHWAY TO CLINIC?

According to the public USPTO record for serial number 79230420, the listed owner(s) include: Recipharm AB (publ), Recipharm AB (publ), Recipharm AB (publ).

What is USPTO serial number 79230420?

Serial number 79230420 is the USPTO application identifier for the mark RECIPHARM PATHWAY TO CLINIC. It is used to track examination, publication, and registration of this trademark.

What is the current status of RECIPHARM PATHWAY TO CLINIC?

RECIPHARM PATHWAY TO CLINIC (79230420) currently shows USPTO status code 709 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover RECIPHARM PATHWAY TO CLINIC?

The public record lists International Classes: 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: RECIPHARM PATHWAY TO CLINIC Serial# 79230420 | status 709; last event INTR | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RECIPHARM PATHWAY TO CLINIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATES

Goods and services

Class	Description	Status	First use
042	Pharmaceutical drug development services; product research and development; conducting clinical tests and trials for others; technical project management for others relating to all the aforesaid services	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jun 10, 2026	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Oct 10, 2025	C71T	CANCELLED SECTION 71	—
Mar 26, 2024	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Aug 16, 2019	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jul 31, 2019	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jul 31, 2019	FIMP	FINAL DISPOSITION PROCESSED	—
Jun 26, 2019	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Mar 26, 2019	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2019	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Jan 8, 2019	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2018	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Nov 16, 2018	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 27, 2018	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 26, 2018	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 26, 2018	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2018	RFNP	REFUSAL PROCESSED BY IB	—
May 4, 2018	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
May 4, 2018	RFRR	REFUSAL PROCESSED BY MPU	—
May 1, 2018	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Apr 30, 2018	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2018	MAFR	APPLICATION FILING RECEIPT MAILED	—
Apr 26, 2018	RFWR	NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW	—
Apr 24, 2018	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Apr 23, 2018	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2018	DOCK	ASSIGNED TO EXAMINER	—
Apr 23, 2018	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Apr 20, 2018	LIMI	LIMITATION FROM ORIGINAL APPLICATION ENTERED	—
Apr 19, 2018	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

RECIPHARM PATHWAY TO CLINIC